Initial Importer
FDA NewsRecalls

Magellan Diagnostics Recalls LeadCare Products

By July 2, 2021February 3rd, 2022No Comments

Magellan Diagnostics Recalls LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests Due to Risk of Falsely Low Results

[pdf-embedder url=”https://dawamedical.com/wp-content/uploads/2021/07/Magellan-Diagnostics-Recalls-LeadCare-I…pdf” title=”Magellan Diagnostics Recalls LeadCare I..”]

You May Also Like

FDA News FDA ImportShield Centralizes Port Oversight and Boosts Efficiency

FDA ImportShield Centralizes Port Oversight and Boosts Efficiency

Dawa Medical
Dawa MedicalApril 29, 2026
FDA News FDA FY 2026 Legislative Agenda: What Device and Drug Makers Should Watch

FDA FY 2026 Legislative Agenda: What Device and Drug Makers Should Watch

Dawa Medical
Dawa MedicalApril 29, 2026
FDA News FDA Aligns U.S. Device Quality Standards with ISO 13485: Implications of the QMSR Rule

FDA Aligns U.S. Device Quality Standards with ISO 13485: Implications of the QMSR Rule

Dawa Medical
Dawa MedicalApril 28, 2026
Share
Tune in for in depth expert insights on FDA approvals and global compliance.
Did you know we have podcast?
Watch now on Youtube
youtube.com/@dawamedical521